September 2, 2019

Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.
Xdrop™ enables single molecule resolution and bias free enrichment of genomic regions longer than 100 kb from as little as 1 ng genomic DNA. Xdrop™ fits seamlessly with any sequencing platform and works equally well with both short-read and long-read sequencing systems.
The Xdrop™ products will be presented at the Genome Science 2019 conference in Edinburgh on September 3rd with an oral presentation titled: "Xdrop™ – Targeted Sequencing into the Dark and Unknown".
"We are excited to launch our Xdrop™ sample preparation products that allow our customers to discover the true biological representation which we all acknowledge is challenging," said CEO Lars Kongsbak. "To put it simply, Samplix allows customers to get more out of their samples by eliminating today’s many shortcomings in sample preparation such as bias and lack of representation, which jeopardize the downstream sequencing".
The Xdrop™ system builds on Samplix’ proprietary technologies to partition single molecules in microfluidics cartridges that are simple to use. The product offering comprises an Xdrop™ instrument for cartridge control, different microfluidics cartridges and several molecular biology consumables optimized to work with the microfluidics cartridges.
Samplix’ sample preparation is unique as it provides for PCR-free enrichment of large single molecules spanning entire genomic regions. The long-range information may comprise phasing, structural variants, repetitive sequences etc. Furthermore, as very little knowledge about the target sequence is required, the Xdrop™ enrichment may equally be applied to investigate unchartered genomic regions.
Samplix is accepting purchase orders for the Xdrop™ instrument at an initial price of €33,000 and shipments will commence immediately.
For more information, please visit www.samplix.com.
May 7, 2026
Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Cirena In...
April 24, 2026
Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer. With over 25 years of industry leadership, Kongsbak will lead the...
April 20, 2026
AxisOne combines artificial intelligence with milestone-based delivery to accelerate lab selection, tighten research execution, and close the accounta...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225